Archive for the ‘Invivoscribe’ Category


March 3rd, 2016 | Posted in 2016, Invivoscribe

Invivoscribe, San Diego, entered into a long-term collaboration with biotech giant Thermo Fisher Scientific to develop cancer tests. Invivoscribe will manufacture and commercialize in vitro cancer tests on Thermo Fisher’s next-generation sequencing platform, the Ion PGM DX system. Invivoscribe has similar development deals for companion diagnostics with Novartis and Astellas Pharma Inc.